Balance Sheet Insights: Upexi Inc (UPXI)’s Debt-to-Equity and Long-Term Debt/Eq Ratios

Kevin Freeman

Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.

In the latest session, Upexi Inc (NASDAQ: UPXI) closed at $2.52 up 2.02% from its previous closing price of $2.47. In other words, the price has increased by $2.02 from its previous closing price. On the day, 5.93 million shares were traded. UPXI stock price reached its highest trading level at $2.5657 during the session, while it also had its lowest trading level at $2.25.

Ratios:

For a deeper understanding of Upexi Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.39 and its Current Ratio is at 3.41. In the meantime, Its Debt-to-Equity ratio is 0.95 whereas as Long-Term Debt/Eq ratio is at 0.68.

Upgrades & Downgrades

In the most recent recommendation for this company, Alliance Global Partners on August 04, 2025, initiated with a Buy rating and assigned the stock a target price of $15.

On June 16, 2025, Cantor Fitzgerald Upgraded its rating to Overweight which previously was Neutral but kept the price unchanged to $16.

Insider Transactions:

Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Nov 20 ’25 when Salkind Gene bought 50,000 shares for $2.55 per share. The transaction valued at 127,500 led to the insider holds 218,750 shares of the business.

Salkind Gene bought 100,000 shares of UPXI for $281,000 on Nov 17 ’25. The Director now owns 168,750 shares after completing the transaction at $2.81 per share. On Nov 17 ’25, another insider, Salkind Gene, who serves as the Director of the company, bought 100,000 shares for $2.65 each. As a result, the insider paid 265,000 and bolstered with 569,470 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, UPXI now has a Market Capitalization of 150994896 and an Enterprise Value of 349527584. For the stock, the TTM Price-to-Sale (P/S) ratio is 7.30 while its Price-to-Book (P/B) ratio in mrq is 0.70. Its current Enterprise Value per Revenue stands at 16.89 whereas that against EBITDA is 5.988.

Stock Price History:

The Beta on a monthly basis for UPXI is -0.28, which has changed by -0.50295854 over the last 52 weeks, in comparison to a change of 0.1028198 over the same period for the S&P500. Over the past 52 weeks, UPXI has reached a high of $22.57, while it has fallen to a 52-week low of $1.90. The 50-Day Moving Average of the stock is -50.22%, while the 200-Day Moving Average is calculated to be -58.43%.

Shares Statistics:

For the past three months, UPXI has traded an average of 5.35M shares per day and 6047450 over the past ten days. A total of 58.89M shares are outstanding, with a floating share count of 52.81M. Insiders hold about 11.86% of the company’s shares, while institutions hold 25.84% stake in the company. Shares short for UPXI as of 1761868800 were 10853775 with a Short Ratio of 2.03, compared to 1759190400 on 15483497. Therefore, it implies a Short% of Shares Outstanding of 10853775 and a Short% of Float of 19.02.

DwinneX
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.